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Sight for mammals is one of the most appreciated senses. In humans there are several
factors that contribute to the increment in all kind of eye diseases. This mini-review will
focus on some diseases whose prevalence is steadily increasing year after year for non-
genetic reasons, namely cataracts, dry eye, and glaucoma. Aging, diet, inflammation,
drugs, oxidative stress, seasonal and circadian style-of-live changes are impacting on
disease prevalence by epigenetics factors, defined as stable heritable traits that are not
explained by changes in DNA sequence. The mini-review will concisely show the data
showing epigenetics marks in these diseases and on how knowledge on the epigenetic
alterations may guide therapeutic approaches to have a healthy eye.
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INTRODUCTION
The eye in mammals is an extraordinarily specialized sensory organ. From the outward–inward
direction, the eye receives light that passing through the cornea reaches the pupil; light is
finally focused by the crystalline lens. When light reaches the neurosensory retina, a series of
phototransduction cascades unfold to convert the photonic energy into a neural signal going from
the photoreceptors to the ganglion cells, where the information travels through the optic nerve into
the brain. In the central nervous system the information is processed and consciously appreciated
as vision (Forrester et al., 2015).
Ocular diseases and consequently, visual impairment, can occur when any cellular component
of the eye becomes dysfunctional. Many ophthalmic pathologies are known to have both heritable
and environmental etiopathological factors (Sanfilippo et al., 2010) (Figure 1). Hence, discovering
the molecular mechanisms of such diseases have positive impacts in the search for therapeutic
approaches (Lipinski et al., 2013; Campbell et al., 2016; Garoon and Stout, 2016). Well-powered
genome-wide association and linkage studies have helped in detecting some of the causes of ocular
diseases. Taking into account the human lifespan, a high percentage (circa 90%) of the genes of the
human genome are expressed in eye structures (Sheffield and Stone, 2011). However, the precise
reason behind developmental genetic features and regulation of gene expression by environmental
factors remains poorly understood.
Gene–environment interaction dynamics are currently known to be potentially mediated
by epigenetic marks established during development and/or acquired by food habits and
environmental factors (Leenen et al., 2016; Hewitt et al., 2017). Limited but increasing evidence
suggest an epigenetic basis in several ocular diseases (Wei et al., 2012; Busanello et al., 2017).
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Epigenetics can be defined as the mitotically and mitotically
heritable potential for gene expression that does not involve
variation in the DNA sequence (Ushijima et al., 2003; Fedoriw
et al., 2012; Waddington, 2012). Epigenetics variations have
an important role in regulating key biological processes, such
as cell differentiation, genomic imprinting, and X-chromosome
inactivation (Fedoriw et al., 2012; Li et al., 2012; Wutz, 2013).
Epigenetic traits are also directly or indirectly related to a wide
range of diseases, from allergies to cancer (Rakyan et al., 2011).
The main mechanisms underlying epigenetics effects include
DNA methylation, post-translational histone modification,
chromatin remodeling, and RNA-associated gene regulation by
non-coding RNAs (Ecker et al., 2017). Wide range of studies
are focused on discovering possible epigenetic regulations in
several pathologies. Although the field is in its beginnings, DNA
methylation is by far the most widely studied epigenetic process,
and many studies have begun to explore the link between DNA
methylation patterns and a wide range of diseases (Hewitt et al.,
2017).
DNA methyltransferase (DNMT) activity is increased in
numerous diseases, and inhibitors of these enzymes are
extensively studied as a pharmacological approach focusing on
epigenetics-based anti-cancer therapy (Lyko and Brown, 2005).
A proof of the potential of enzyme inhibitors involved in placing
epigenetic marks in the DNA is the approval by the US Food
and Drug Administration of a DNMT inhibitor, 5-azacytidine, as
anti-tumor agent (see Kaminskas et al., 2005; Sampol et al., 2017,
and references therein).
DNA methyltransferases are a family of enzymes that
methylate DNA at the carbon-5 position of cytosine residues.
Methylated DNA can then interact with methyl-binding proteins
that function as adaptors between patches of methylated DNA
and chromatin-modifying enzymes (e.g., histone deacetylases
and histone methyltransferases). Histone-modifying enzymes
then covalently modify histones to induce the formation of
chromatin structures that repress gene transcription. There are
two types of DNMTs inhibitors, namely, nucleoside and non-
nucleoside inhibitors (Lyko and Brown, 2005). Acetylation or
deacetylation of histone N-terminal ends is able to produce
changes in the interaction between histones and DNA in
chromatin, this chromatin remodeling being identified as a key
step to regulate gene expression. Histone acetyltransferases and
deacetylases are, respectively, the enzymes committed to the
addition and removal of acetyl groups from lysine residues
within histone N-terminal ends; they play an essential role in
developmental processes, whereas they appear as dysregulated in
a variety of diseases (Nusinzon and Horvath, 2005; Verdone et al.,
2005). Generally, hyperacetylation is associated to transcriptional
activation, while hypoacetylation is linked to silencing (Saha and
Pahan, 2006).
During the last decade, technological advances applied to
functional genomics have illustrated a new scenario in the
field of RNA biology. To date, approximately 35% (about
57,000; GENCODE version 17) (Consortium, 2012) of the
human sequences identified by the ENCODE project, include
open reading frames but most of the remaining ones are
known as “non-coding” RNAs. Non-coding RNAs are classified
in different groups in accordance to their length, function,
localization, orientation, or other criteria. Overall, their relevance
is increasingly acknowledged by researchers because they may
regulate gene expression thus arising as epigenetic players.
Countless microRNAs have been discovered and described in the
past few years (Morozova et al., 2012; Romano et al., 2017) and
they are attributed far more physiological roles than expected
when first discovered. There are still questions to sort out before
apprehending the real relevance of non-coding RNAs. As an
example some of those RNAs which are not translated into
any protein may arrange into silencing (RISC) complexes that
block the expression of given genes (Esquela-Kerscher and Slack,
2006). Other identified small RNA species are known as: PIWI-
interacting RNAs (Li and Liu, 2011) circular RNAs (Tay et al.,
2014), or telomeric RNAs (Schoeftner and Blasco, 2010). Longer
RNAs include the so-called long non-coding RNAs, which are
longer than 200 nucleotides and represent more than 20% of the
human genome. It is yet unclear their relevance and function
although evidence points to a substantial role in cell growth and
apoptosis (Hung et al., 2011; Zhang and Peng, 2015), and in
cell pluripotency and differentiation (Klattenhoff et al., 2013).
Moreover, it is suggested that these long nucleic acids may act in
cooperation with chromatin modifiers, thus becoming players in
epigenetics-related regulation of gene expression (De Lucia and
Dean, 2011; Kitagawa et al., 2012; Marchese and Huarte, 2014).
Several factors that result in changes at the epigenetic level also
impact on the health of the eye. Such factors include aging, diet,
inflammation, drugs, oxidative stress, and seasonal and diurnal
changes (Handy et al., 2011; Mazzio and Soliman, 2012). In the
present article we revise the epigenetic determinants of the most
prevalent ocular diseases: cataracts, glaucoma, and dry eye.
CATARACTS
Cataracts are the result of opacity (clouding) in the crystalline
lens, blocking the transmission of light that reaches the retina.
According to the World Health Organization (WHO) it is the
number one leading cause of reversible vision loss; although it is
reversible by means of appropriate interventions, WHO estimates
that, worldwide, cataracts are the cause of approximately 50% of
the cases of blindness (Mahdi et al., 2014; Patil et al., 2014). Due to
the increase of life expectancy that leads to progressive expansion
of the elderly population, the National Eye Institute, estimates the
number of people in the U.S. with cataract will double by the
2050, from the current 24.4 million to about 50 million cases.
Cataracts may start as early as in 40 years old individuals and
the risk, which increases with age, is estimated in 70% in 80-
year-old caucasians and in 53 and 61% in afroamericans and
hispanic americans, respectively. It is known that the eye has
many protective mechanisms but they succumb upon sustained
challenging by environmental stressors like electrophilic reactive
species, drugs, inflammation, radiation, sunlight, and diabetes
(Figure 1). Currently, there is not any pharmacological therapy
for treatment or prevention for of cataracts; fortunately clear
vision can be restored by surgical intervention and replacement
of the cloudy lens by a synthetic transparent one. However, it is
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FIGURE 1 | Representative scheme of eye diseases showing the estimated percentage of heritability as well as the percentage of non-inheritable factors some of
which lead to specific epigenetic patterns in cataracts, glaucoma, and ocular surface diseases.
important to highlight complications associated to surgery and
to the emotional concerns and costs derived from surgery and its
potential complications.
Klotho gene family seems to be involved in the susceptibility
and development of cataracts. Interestingly, differential
epigenetics patterns in the DNA around these genes are
found in the senile cataract (Jin et al., 2015). Klotho is a quite
recently discovered gene family showing close correlation
between expression and age. Klotho gene family consists of three
members, α-Klotho, β-Klotho, and γ-Klotho, that encode type I
transmembrane glycoproteins with extracellular β-glycosidase-
like domains. Expression of these proteins appears as a factor
related to the progression of age-related and chronic diseases in
mammals. These proteins seemingly regulate the metabolism of
several vitamins and minerals such as vitamin D and calcium and
it is suggested that they have a role in immunological functions
and in protecting the cardiovascular system (Arking et al., 2003;
Kurosu et al., 2005; Alesutan et al., 2013) (Figure 1).
In studies performed on cataract models, an age-dependent
increased methylation of Klotho’s gene promoters has been
detected (Zhang et al., 2017). On the other hand, it is well-known
that lens crystallin proteins play a crucial role in maintaining
lens transparency (Andley, 2009; Christopher et al., 2014). As a
major structural protein component, α-crystallin represents 35%
of all crystallins in the lens (Thampi et al., 2002) and it serves as
molecular chaperone to prevent aggregation of other crystallins
(Horwitz, 2003). Recent studies showed a decreased level of
α-crystallin in age-related nuclear cataract. The reduction of
α-crystallin expression is linked with the hypermethylation of the
CpG island in the CRYAA gene promoter (Table 1). Moreover,
the treatment with DNA-methylation inhibitors results in
restoring CRYAA gene expression (Zhou et al., 2012a,b). Such
evidence sustains an epigenetic-based repression of CRYAA in
age-related nuclear cataracts. A reasonable therapeutic approach,
which is already suggested to treat cancer, would be the use of
inhibitors of the methyltransferase since in this way it would be
possible to treat this cause of cataracts.
Another epigenetic-based silencing has been reported for a
nuclear factor, namely the erythroid 2-related factor 2 (Nrf2).
This protein is a transcriptional activator that may protect the
lens by binding to antioxidant response elements, which are
Cis-acting enhancer sequences (cis-acting) in regulatory locus
of genes related to detoxification. Although this suppression
has been linked to aging and cataract formation, Nrf2 action
negatively correlates with a protein called Keap1, whose
expression increases with age. In fact, it seems that when Keap1
increases, it stimulates the proteasome-mediated degradation of
Nrf2 that in turn would suppress Nrf2− dependent antioxidant
protection of the lens (McMahon et al., 2003). Results of the
analysis performed using age-related cataract crystalline lenses
showed a significant demethylation in Keap1 and a decline in
Nrf2, these results being similar to the ones found in lenses from
a group of patients between 65 and 80 years of age (Gao et al.,
2015).
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GLAUCOMA
Glaucoma refers to a wide spectrum of ocular conditions with
multifactorial etiology distinguished by progressive irreversible
optic neuropathy and peripheral visual field loss (Casson et al.,
2012). Glaucoma is the second leading cause of vision loss, and
it has been estimated that about 61 million people worldwide
suffer from this disease; the number of aﬄicted individuals
may increase to about 80 million by year 2020 (Quigley
and Broman, 2006). Risk factors that contribute to glaucoma
development are numerous and include increased intraocular
pressure (IOP), age, and genetic mutations (Topouzis et al., 2009,
2011) (Figure 1). Strong evidence shows that predisposing single
nucleotide polymorphisms (SNPs) and environmental effects are
also key factors in the development of glaucoma (Chen et al.,
2012; Guo et al., 2012).
Glaucoma courses with epigenetic alteration in several ocular
structures. For instance, histone 2 and 3 deacetylase (HDAC 2
and 3) expression are significantly upregulated after acute optic
nerve injury; however, histone H4 acetylase is downregulated.
These data indicate that epigenetic patterns do vary upon optic
nerve damage (Schmitt et al., 2014). Moreover, inhibition of
retinal HDAC activity in the retina was successfully able to both,
preserve the expression of a representative retinal ganglion cell-
specific gene and attenuate cell loss in response to optic nerve
damage (Pelzel et al., 2010). In addition, a positive effect was
observed after using valporic acid (VPA) as a neuroprotective
agent for injured retinae, this agent is suggested to directly
inhibit HDAC activity and cause histone hyperacetylation (Phiel
et al., 2001; Biermann et al., 2010). These reports revealed that
abnormal histone acetylation/deacetyalation might be related to
retinal ganglion cell damage in glaucoma.
A different aspect of the pathophysiology of glaucoma
is the accumulation of extracellular matrix (ECM) in the
trabecular meshwork, the conventional pathway of aqueous
humor drainage. When the trabecular meshwork is blocked
by an abnormal structure in the ECM, aqueous humor does
not find a way out and it accumulates within the eye, so
TABLE 1 | Ocular disorders and the corresponding altered epigenetic factors.
Disease Epigenetic factors Reference
Cataract (1) Hypermethylation of Klotho’s
gene promotor
(2) Hypermethylation of the CpG
island in CRYAA gene promotor
(3) Demethylation of Keap1
Zhou et al.,
2012a,b; Gao
et al., 2015;
Zhang et al., 2017
Glaucoma (1) Upregulation of histone 2 and 3
deacetylase (HDAC 2 and 3)
(2) Downregulation of histone H4
acetylase
(3) Increase in DNA methylation
Schmitt et al.,
2014; McDonnell
et al., 2016
Ocular surface
disorders
(1) Altered histone methylation
pattern
(2) Involvement of long non-coding
RNAs in keratoconus
Ito, 2007;
Szczesniak et al.,
2017
IOP increases. Apart from subsequent fibrosis, another relevant
finding is the hypoxic environment of the trabecular meshwork of
glaucomatous eyes; hypoxia leads to substantial increase in DNA
methylation in locuses related to the regulation of the expression
of the pro-fibrotic (TGF)β1 factor and the Ras protein activator
like 1 (RASAL1) (McDonnell et al., 2016) (Figure 1).
Convergent evidence suggests an association between
glaucoma and some genetic variants in the CDKN2B-CDKN2A
gene cluster at 9p21 chromosome (Wiggs et al., 2012). CDKN2B-
AS, also known as ANRIL (Antisense Non-coding RNA in
the INK4 Locus), is a long non-coding RNA transcribed in the
antisense direction of CDKN2B-CDKN2A (Pasquale et al., 2013).
This chromosome locus is a hotspot for numerous disease related
polymorphisms; in fact, ANRIL has been recently associated
inter alia to several cancers, diabetes, and glaucoma (Table 1)
(Congrains et al., 2013). Although the mechanism behind the
association between glaucoma and ANRIL is poorly understood,
it seems to be more epigenetic than genetic. Various hypothesis
have been proposed to explain the link such as that occurrence
of polymorphisms at this locus changes the expression of target
genes responsible of cell cycle regulation, subsequently inducing
retinal ganglion cell apoptosis (Burdon et al., 2011). Another
study suggests that the ANRIL region is involved in regulating
the vulnerability of the optic nerve subsequent to the progression
of the disease (Pasquale et al., 2013).
OCULAR SURFACE DISORDERS
The surface of the eye is constantly facing external environmental
stress; it contains the cornea, which is highly responsible of the
refractive effect of the eye. It is highly innervated, avascular and
transparent and it obtains nutrients from the aqueous humor
and the tear film (Brubaker et al., 1975; Forrester et al., 2015).
The ocular surface is prone to harmful events starting by tear-
film disruption that may end up in a dry eye, which is a
prevalent disease. Several studies have suggested the involvement
of epigenetics in the pathophysiology of disorders affecting the
ocular surface.
Dry eye is one of the under-diagnosed ocular surface diseases.
It has become the most common ocular surface alteration
worldwide and it is defined by the International Dry Eye
Workshop (DEWS) as “a multifactorial disease of the tears and
ocular surface that results in symptoms of discomfort, visual
disturbance, and tear film instability with potential damage to the
ocular surface. It is accompanied by increased osmolarity of the
tear film and inflammation of the ocular surface” (International
Dry Eye Workshop (DEWS) Definition and Classification, 2007).
Previous studies attributed dry eye to inflammation and
the release of pro-inflammatory cytokines such as the
promotion of the activity of nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB), but also dry eye
may have an altered histone methylation pattern (Ito, 2007).
Apart from inflammatory components, dry ocular surface is
overexposed to infective agents, to environmental allergens
and pollutants (Figure 1). Another quite common corneal
disease is keratoconus, which often comes accompanied with
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dry eye. Keratoconus is a degenerative disorder characterized
by thinning of the corneal stromal layer leading to a cornea
with conical shape and consequently resulting in loss of
visual capability. A very recent database has been created
in order to characterize keratoconus transcriptome and to
identify long non-coding RNAs which might be involved in
keratoconus etiology. These results have shown that some
of those non-coding RNAs could affect the expression of at
least 996 genes in keratoconus patients (Table 1) (compared
to healthy subjects). The differentially regulated genes include
very relevant cellular metabolism and fate regulators such as
TGF-β and SMAD9, SMAD6, TGFB3, and TGFBR1 members
of Hippo/Wnt pathways (Szczesniak et al., 2017). All those
have been previously associated with keeping ocular health
(Morgan et al., 2013). Based on these epigenetics-based
data, novel therapies are being approached and investigation
on novel epigenetics mechanisms are undertaken to have
a better understanding of the etiology of ocular surface
disorders.
In summary, epigenetics play an important role in the
physiology of numerous ocular diseases. Understanding such
changes could open a novel window for therapeutical approaches
in addition to current therapies. Moreover, further investigation
could be helpful for early detection of pathologies with
irreversible effect of vision loss such as glaucoma as well as
disorders of the retina where solutions are often aiming to treat
the symptoms rather than the disease itself.
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